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To track drainage of lymph-borne small and large
antigens (Ags) into the peripheral lymph nodes and
subsequent encounter by B cells and follicular den-
dritic cells, we used the approach of multiphoton
intravital microscopy. We find a system of conduits
that extend into the follicles and mediate delivery of
small antigens to cognate B cells and follicular den-
dritic cells. The follicular conduits provide an efficient
and rapid mechanism for delivery of small antigens
and chemokines such as CXCL13 to B cells that
directly contact the conduits. By contrast, large
antigens were bound by subcapsular sinus macro-
phages and subsequently transferred to follicular B
cells as previously reported. In summary, the findings
identify a unique pathway for the channeling of small
lymph-borne antigens and chemoattractants from
the subcapsular sinus directly to the B cell follicles.
This pathway could be used for enhancing delivery
of vaccines or small molecules for improvement of
humoral immunity.
INTRODUCTION
Lymph nodes (LNs) are strategically positioned and functionally
partitioned for facilitating the initiation of immune responses to
foreign antigens (Ags). Ags drain into the node via the afferent
lymph or are delivered by dendritic cells (DCs) (Kissenpfennig
et al., 2005). A series of cellular interactions in anatomically
distinct compartments of the LN then governs the development
of both a cellular and a humoral immune response aimed at the
elimination of the eliciting Ag (von Andrian and Mempel, 2003).
Whereas T cells rely on processed Ag presented in the context
of major histocompatibility complex (MHC) molecules, B cells
recognize Ag in its native, unprocessed form via their immuno-
globulin (Ig) receptors (Germain, 1994; Rajewsky, 1996). The264 Immunity 30, 264–276, February 20, 2009 ª2009 Elsevier Inc.anatomical site in which B cells first encounter Ag depends on
the route of infection, i.e., intravenous (i.v.), mucosal, or subcuta-
neous (s.c.). Naive B cells circulate through the secondary
lymphoid organs, including the spleen and peripheral LNs, to
increase the likelihood of Ag encounter (Allen et al., 2007; Hauser
et al., 2007; Okada andCyster, 2006; Schwickert et al., 2007; von
Andrian and Mempel, 2003). Their accumulation in the follicular
region is controlled by chemokines such as CXCL13, which is
secreted by specialized stromal cells, including follicular den-
dritic cells (FDCs) and follicular stromal cells (FSCs) (Allen and
Cyster, 2008; Gunn et al., 1998). On encounter with Ag, B cells
are activated and migrate to the T-B cell border, where they
interact with cognate T cells (Garside et al., 1998; Okada et al.,
2005). Given their central location, FDCs provide an efficient
site for retention of Ag that enters via the blood or lymph. Ag is
retained chiefly by complement receptors (CD21 and CD35)
and Fc receptors (FcgRIIB) (Carroll, 2004; Nimmerjahn and Rav-
etch, 2006; Tew et al., 1990). Moreover, FDCs foster develop-
ment of the germinal center reaction once B cells are activated
(Cyster et al., 2000; Kosco and Gray, 1992). This specialized
environment, in which B cells undergo expansion, class-switch
recombination, and somatic hypermutation, promotes differenti-
ation of the Ag-specific B cells into memory or plasma cells
(MacLennan, 1994; Kelsoe, 1995; Rajewsky, 1996; Victoratos
et al., 2006).
In the spleen, marginal-zone B cells transport Ag into the folli-
cles (Cinamon et al., 2008; Ferguson et al., 2004; Youd et al.,
2002; Guinamard et al., 2000; Pozdnyakova et al., 2003).
However, LNs lack an equivalent B cell subset. Earlier studies
reported transport of Ag into the LN follicles via a subset of
subcapsular sinus (SCS) macrophages identified as binding
a fusion protein of the N-terminal cysteine-rich (CR) domain of
the mannose receptor fused to the Fc region of human IgG
(CRFc+) (Berney et al., 1999; Martinez-Pomares et al., 1996). In
addition, nonphagocytic cells of dendritic appearance have
been implicated in Ag transport (Szakal et al., 1983). An alterna-
tive mechanism is a system of conduits that permeates both LNs
and spleen, yet these are generally considered to mainly supply
the T cell areas of the LNs (Gretz et al., 2000; Okada and Cyster,
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are differentially taken up and subsequently processed accord-
ing to size suggests a more selective process. Large lymph-
borne Ags are bound by SCS macrophages, which line the floor
of the LN (Carrasco and Batista, 2007; Junt et al., 2007; Phan
et al., 2007) and are made available to the underlying B cell
compartment. Thus, cognate B cells survey the SCS for specific
Ag while immune complexes (ICs) are taken up by follicular (FO)
B cells via complement receptors CD21 and CD35 (Phan et al.,
2007). By contrast, small Ags (less than 70 kDa) either enter
conduits leading to the paracortical (T cell) area (Sixt et al.,
2005) or diffuse via gaps in the SCS floor into the follicles, where
they are taken up by cognate B cells (Pape et al., 2007).
To directly compare transport of large and small Ags into the
B cell follicles in vivo, we have used a combination of multipho-
ton intravital microscopy (MP-IVM) (Lindquist et al., 2004;
Mempel et al., 2004; Miller et al., 2002; Shakhar et al., 2005),
electron microscopy, confocal analyses of cryosections (Carra-
sco and Batista, 2007; Gretz et al., 2000; Pape et al., 2007;
Sixt et al., 2005), and flow-cytometry analyses (FACS) of periph-
eral LNs (Phan et al., 2007). As reported earlier, large Ags are
transported into B cell areas via FO B cells in a complement-
dependent manner. By contrast, a novel network of FO conduits
was identified that mediates rapid transport of small soluble-
protein Ags from the SCS into the B cell follicular region.
Moreover, the conduits provide a source of B cell chemokine
(CXCL13), which is secreted by FSCs. Together, the results
suggest a pathway for channeling small Ags and chemokines
into the B cell area.
RESULTS
Differential Transport of Large and Small Ags
To directly compare the uptake of large and small Ags by
FDCs, we injected mice s.c. in the hind footpad with a small
volume of soluble ICs prepared from fluorescently labeled key-
hole limpet hemocyanin (KLH) (large, monomer 450 kDa) or tur-
key egg lysozyme (TEL) (small, 14 kDa). On cryosections of
draining popliteal LNs (pLNs), we identified uptake of TEL on
FDCs 6 hr after injection (Figure 1A, right panel). By contrast,
negligible amounts of the larger KLH Ag were observed at
this time (Figure 1A, left panel). However, by 24 hr after injec-
tion, similar amounts of TEL and KLH had accumulated on
FDCs (results not shown). Similar results were obtained with
mice actively immunized by a previous injection of TEL or pas-
sively immunized with specific rabbit polyclonal antisera (re-
sults not shown). Because IC formation in situ upon injection
of free Ag more closely mimics the physiological process, we
passively immunized mice in subsequent experiments by intra-
peritoneal (i.p) injection of antiserum several hours before s.c.
injection of Ag. A similar approach was reported by Phan
et al. for tracking uptake and transport of large Ag into the
B cell follicles (Phan et al., 2007).
To more closely examine the kinetics of uptake of large and
small lymph-borne Ags by FDCs, we injected passively immu-
nized mice s.c. in the hind flanks with an equal molar mixture
of large (Phycoerytherin [PE], 240 kDa) and small (TEL, 12–
14 kDa) Ags. Draining inguinal LNs were harvested at various
times for analysis. Both Ags were present in the SCS sinus by15 min, and small Ag was first observed on FDCs at 2 hr after
injection, whereas PE Agwas not observed on FDCs until at least
8 hr, consistent with the report by Phan et al. (Phan et al., 2007)
(Figure 1B). By 24 hr, both Ags were observed on FDCs, consis-
tent with our previous finding with KLH and TEL in the pLN. Thus,
small Ags are taken up by FDCs more rapidly than large ones in
both the pLNs and inguinal LNs, although the process is slower in
the latter, probably because of less efficient drainage from the
injection site. Small Ag (TEL) injected in nonimmune mice did
not detectably bind to FDCs and was not retained in the draining
LN (Figure S1 available online).
ICs composed of large Ags such as PE are transported by
naive B cells from the SCS into the follicles and transferred to
FDCs in a complement-receptor-dependent manner (Phan
et al., 2007). To evaluate the relative efficiency of FO B cell trans-
port of large and small Ags, we analyzed by FACS single-cell
suspensions prepared from inguinal LNs at varying times after
s.c. injection. PEwas found on FOB cells as early as 2 hr, peaked
at 8 hr, and then decreased at 24 hr after injection (Figure 1C).
Uptake was dependent on expression of CD21 and CD35 on
FO B cells, given that characterization of Cr2 mixed chimeric
mice identified substantially greater amounts of PE Ag on Cr2+
than on Cr2 B cells, consistent with the report by Phan et al.
(Phan et al., 2007) (Figure S2). By contrast, B cell uptake of small
Ags was less pronounced, with maximal uptake at 2 hr and
subsequent decrease (Figure 1C). Thus, B cell transport of small
Ags is not as efficient as with large Ags, yet the former is identi-
fied on FDCs within a shorter time period (Figures 1B and 1C).
This suggests that small Ags are transported to FDCs by both
B cell-dependent and B cell-independent mechanisms.
Conduits Mediate Small-Ag Transport into Follicles
Previous studies on Ag transport in secondary lymphoid organs
have identified a system of conduits that originate from the SCS
and permeate the interfollicular zone and paracortical T cell area
in LNs (Gretz et al., 2000; Sixt et al., 2005). These conduits
consist of a core of collagen fibers ensheathed by a basement
membrane and a layer of fibroblastic reticular cells (FRCs), form-
ing an inner tubular space accessible to small molecules with
a hydrodynamic radius of approximately 4–5 nm or an approxi-
mate molecular weight of 70 kDa (Gretz et al., 2000; Sixt et al.,
2005; Nolte et al., 2003). Because DCs can sample Ags from
conduits, these were first proposed to have an important func-
tion in facilitating the presentation of lymph-borne Ags to
T cells by conduit-associated DCs (Sixt et al., 2005). In addition,
Qi et al. found that DCs could also present intact Ag to B cells
when these transit the T zone after entering the LN via high endo-
thelial venules (HEVs) (Qi et al., 2006).
The reticular collagen-fiber network (which, under the illumina-
tion conditions required for multiphoton fluorescence excitation,
becomes visible because of second-harmonic generation) within
B cell follicles is less abundant than that in T cell areas (Gretz
et al., 2000). To determine whether collagen fibers in B cell folli-
cles are also associated with conduits and whether these partic-
ipate in channeling Ag directly into the B cell follicle, we injected
nonimmune mice s.c. in the hind footpad with a mixture of TEL
(12–14 kDa) conjugated either to the large-molecular-weight
(240 kDa) fluorochrome PE (‘‘large TEL,’’ TEL-PE) or to the
small-molecule (1.2 kDa) dye Alexa Fluor 633 (‘‘small TEL,’’Immunity 30, 264–276, February 20, 2009 ª2009 Elsevier Inc. 265
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Small-Antigen Transport to B Cell FolliclesFigure 1. Uptake of Ag on FDCs in Peripheral LNs Is Size Dependent
(A) Confocal fluorescence micrographs of histological sections of pLNs show delay of KLH deposition on FDCs (blue, Cy5-anti-CD35) relative to TEL deposition,
6 hr after injection of IC. The scale bar represents 50 mm. Images are representative of at least three independent experiments.
(B and C) Immunized mice were left untreated (t = 0) or injected with a mixture of 10 mg TEL Alexa 488 and 10 mg B-PE s.c. in the hind flanks.
(B)The draining inguinal LNs were removed at various times, and the deposition of IC on FDCs was analyzed by confocal microscopy with a monoclonal antibody
specific for CD35 for labeling FDCs.
(C) In vivo uptake of IC containing small or large Ags by polyclonal B cells was analyzed by FACS. The percentages of B220+ cells that have acquired TEL-IC or
PE-IC are indicated and are represented in the graph as the mean values ± standard error of the mean (SEM) from at least three LNs. CD45.1+ cells were added
during processing of inguinal LNs from CD45.2+ recipient mice for controlling for ex vivo capture of IC. Statistical significance was determined with a one-tailed,
paired Student’s t test.266 Immunity 30, 264–276, February 20, 2009 ª2009 Elsevier Inc.
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Small-Antigen Transport to B Cell FolliclesA633-TEL) and imaged the pLN byMP-IVM directly thereafter. In
addition, to track entry of Ags into the follicles, we seeded
recipient mice with fluorescently labeled naive polyclonal
primary B cells and with BCR transgenic MD4 B cells that recog-
nize TEL with high affinity. Notably, small TEL was first observed
within the SCS and then started to fill FO conduits in a centripetal
direction within less than 2 min after injection (Figures 2A and 2B
and Movie S1). Importantly, the small Ag became detectable in
the interstitial space and on MD4 B cells only with several
minutes delay (Figure 2C), suggesting that conduits did not
accumulate the Ag from an interstitial pool, but conversely that
conduits delivered the Ag to the interstitium. By contrast, the
large TEL conjugate was excluded from the conduits, as
expected, on the basis of its size (Figures 2A and 2B). The
absence of large TEL-PE conjugates from the follicular conduits
is consistent with observations of exclusion of proteins of
approximate size over 70 kDa (Gretz et al., 2000; Sixt et al.,
2005). We noted, though, that at a time point when the concen-
tration of small TEL had reached its maximum in the conduits,
large TEL began to slowly penetrate the follicle from the SCS in
an interstitial pattern, independent of conduit filling (Figures 2A,
2B, and 2D). We speculate that this delayed entry of the large
Ag occurs through a distinct mechanism, possibly by diffusion
(Pape et al., 2007) or by binding to non-Ag-specific B cells after
shuttling of the Ag across the floor of the SCS (Phan et al., 2007).
To further examine the size exclusion of FO conduits, we in-
jected mice s.c. in the footpad with fluorescently labeled KLH
(450 kDa) and dextrans (of either 40 or 150 kDa molecular
weight). Confocal analysis identified localization of these Ags in
the SCS within minutes of injection, but only the small, 40 kDa
dextran also entered the conduits (Figure S3 and data not
shown). Thus, FO conduits appear to have a similar size-exclu-
sion limit as those characterized in the T cell area (Gretz et al.,
2000).
Conduits Are Structurally Similar in the T and B Cell
Areas
Conduits within the T cell area are characterized by a type I col-
lagen core ensheathed by a fibronectin-containing basement
membrane. They are derived from FRCs and are identified by an-
tibodies to ER-TR7 and gp38 (Katakai et al., 2004). To further
characterize the conduits in the B cell follicles, we injected naive
mice s.c. in the footpad with labeled TEL and immunohisto-
chemically analyzed cryosections of the in situ-fixed draining
pLNs. The B cell areas (marked by their central clusters of
CD35+ FDCs) contained a network of conduits positive for type
I collagen, fibronectin, perlecan, and ER-TR7; this network
was, however, less dense than that of T cell areas (Gretz et al.,
2000; Sixt et al., 2005) (Figure 3A). Importantly, TEL colocalized
with conduits, supporting the MP-IVM results indicating that
small Ag drains from the SCS into the follicles via conduits (Fig-
ures 3B and 3C). Analysis at higher magnification revealed that
TEL is flanked by markers of the conduit-forming FRCs, such
as ER-TR7 and gp38, as well as by fibronectin (Figures 3B and
3C). Moreover, TEL was found in association with CD11c+ DCs
and B220+ B cells (Figure 3C). These results combined with
the observation of size exclusion support the interpretation that
small Ags enter the follicles via the FO conduits.To further characterize the FO conduits, we prepared pLNs
from naivemice for ultrastructural analysis. Electronmicroscopic
(EM) examination of the SCS floor and the underlying B cell
follicles revealed the presence of conduit structures originating
from the floor of the SCS and extending deep into the B cell
area (Figure 3D i, ii). The B cell area conduits are composed of
bundles of collagen-like fibrils partly wrapped by stromal cells
that closely resemble FRCs defined for paracortical conduits
(Sixt et al., 2005) (Figure 3D iii, iv). The openings (approximately
1 mm) of conduits to the SCS would provide access for passive
drainage of small Ags into the follicles (Figure 3D ii). However,
the tightly packed collagen fibers (less than 10 nm spacing)
would exclude free diffusion of large molecules. Thus, on the
basis of ultrastructural analysis, the conduit structures extending
into the B cell area are similar to those identified in the paracort-
ical regions (Gretz et al., 2000; Sixt et al., 2005).
B Cells Rapidly Acquire Small Ag from Conduits
Earlier studies proposed that Ags of a size comparable to that of
TEL drain passively via fenestrations in the SCS floor into the
underlying follicles, where they are bound by cognate B cells
(Pape et al., 2007). Our finding that conduit filling with s.c.-
injected TEL precedes the detectable appearance in the intersti-
tium and on B cells (Figure 2C) suggests that conduits might in
addition facilitate more efficient direct delivery of Ag to B cells.
To test this possibility, we injected limiting amounts of TEL into
naive mice that had been seeded with a mixture of fluorescently
labeled naive MD4 and polyclonal B cells 20 hr earlier. Under
these conditions, only a fraction of MD4B cells acquired Ag early
after injection (Figure 4A and Movie S3), unlike what would be
expected if the Ag was distributed through the follicle solely by
diffusion. On closer inspection, it was noticed that the majority
of Ag+ B cells were closely associated with an Ag-filled conduit
and that the distance from each MD4 B cell to the nearest con-
duit correlated with the amount of Ag it had acquired (Figures
4A–4C). Moreover, the instantaneous velocity of cognate cells
that bound TEL rapidly and transiently declined upon binding
of TEL, whereas Ag-free MD4 and control B cells were unaf-
fected (Figure S5 and Movie S1). TEL, like hen lysozyme (HEL),
binds MD4 B cells with high affinity. To test whether the rapid
kinetics of uptake of the high-affinity Ag TEL is representative
of Ag uptake by naive B cells with commonly lower affinity for
Ags, we repeated the experiment with duck lysozyme (DEL),
which binds the MD4 BCR at 1000-fold lower affinity. Indeed,
when a similar amount of DEL was injected s.c. and its entry
into the draining pLN was analyzed by MP-IVM, the kinetics of
Ag accumulation on MD4 B cells were similar as with the high-
affinity TEL Ag (Figure S5 and Movie S4).
One explanation for the increased efficiency of Ag uptake by
MD4 cells most proximal to the conduits is that B cells interact
directly with conduits, as has been proposed for DCs in the para-
cortical region (Sixt et al., 2005). Analyses of FO conduits by EM
identified gaps in the stromal cell-wrapped conduit, in that the
cells appear to ‘‘grasp’’ the conduit without completely envelop-
ing it (Figure 3D i–iii). Inspection of FO conduits by EM identified
B cell pseudopods in direct contact with the collagen core
(Figure 4D iii). Thus, Ag within the conduits is accessible to FO
B cells via the gaps in the FSC envelope.Immunity 30, 264–276, February 20, 2009 ª2009 Elsevier Inc. 267
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Activation
The finding that small Ag enters the follicles via conduits and is
rapidly acquired by cognate B cells raised the question of
whether Ag trafficking through conduits makes B cell activation
more efficient. To compare the relative efficiency of uptake of
large TEL-PE and small TEL Ag by cognate B cells, we seeded
naive mice with MD4 B cells and then injected them s.c. in the
hind flank with a mixture of fluorescently labeled Ag. Inguinal
LNs were harvested at various times and analyzed by FACS.
Although some MD4 B cells acquired TEL within 30 min after
injection, they were devoid of the large Ag TEL-PE. By 60 min,
uptake of small TEL by MD4 B cells was maximal, whereas
only half as many MD4 B cells acquired TEL-PE. The acquisition
of large TEL-PE by the MD4 B cells increased further at both 2
and 4 hr, nearing the maximal levels of small TEL acquired at
60 min. These results indicate that MD4 B cells acquired small
TEL more rapidly than the larger Ag when they were coinjected
(Figure 4E). Thus, small Ags draining via conduits are more read-
ily accessible to cognate B cells than large Ags entering via other
pathways.
To evaluate the quality of the interactions between cognate
B cells and their Ag, i.e., whether they led to B cell activation,
we seeded wild-type mice with MD4 B cells and 20 hr later
injected them separately in the hind flank with either TEL-PE or
TEL at equivalent TEL concentrations. Inguinal LNs were
harvested at various times, and MD4 B cells were analyzed for
upregulation of CD86 as an early marker of activation
(Figure 4F). Within 4 hr of Ag encounter, a higher frequency of
MD4 B cells upregulated CD86 in response to small TEL as com-
pared to large TEL-PE (Figure 4F). By 6 and 8 hr, approximately
equivalent numbers of MD4 B cells that encountered either TEL
or TEL-PE had upregulated CD86 (Figure 4F). Thus, B cell activa-
tion occurredmore rapidly after exposure to small Ag (within 2 hr)
compared to MD4 B cells that encountered large TEL-PE.
B cell encounter with cognate Ag leads to their movement to
the T-B cell border for interaction with cognate T cells (Garside
et al., 1998; Okada et al., 2005), and this approach has been
used as an indicator of B cell activation (Carrasco and Batista,
2007; Junt et al., 2007; Pape et al., 2007; Qi et al., 2006). To
confirm B cell activation by small, as opposed to large, TEL
Ags, we quantified the localization of MD4 cells at the T-B cell
border (Figure 4G and Figure S4). In control mice (no Ag), most
MD4 B cells were observed within the follicle; only 15% of
MD4 B cells were in a follicular border zone (approximately
22 mm inward from the edge of the follicle distal to the SCS) or
were extrafollicular. In contrast, in LNs from mice treated with
small TEL 8 hr earlier, 51% of MD4 B cells were located in theborder and extrafollicular zone, whereas those from TEL-PE-
injected mice were similar to cells that had not been exposed
to either TEL Ag (Figure 4G and Figure S4). Notably, by 24 hr,
a similar percentage of border and extrafollicular MD4 B cells
were identified in LNs from TEL or TEL-PE treated mice
(Figure S4). These observations indicate that the rapid delivery
of TEL via FO conduits results in amore rapid activation of B cells
compared to the delayed activation by large Ag, which is
excluded from the conduits.
Do FO Conduits Guide B Cells to Ag via CXCL13
Chemokine?
Trafficking of T cells within the paracortical region is not
thought to be entirely random but guided by conduit-forming
FRCs bearing specific chemokines that promote T cell motility
in a haptotactic or haptokinetic fashion (Bajenoff et al., 2006;
Mempel et al., 2006; Okada and Cyster, 2007; Worbs et al.,
2007). Similarly, CXCL13, produced by stromal cells including
FDCs (CD35+) and FSCs (CD35), probably regulates B cell
migration in follicles (Allen and Cyster, 2008; Cyster et al.,
2000; Nolte et al., 2003). To examine whether FO conduits
harbor CXCL13 in addition to small lymph-borne Ags, we in-
jected naive mice in the footpad with labeled TEL, fixed
pLNs in situ, and analyzed cryosections by immunostaining.
Staining with anti-CXCL13 identified a reticular pattern within
the B cell region that colocalized with both FDCs (CD35+)
and conduits (identified by fibronectin and collagen I) (Figures
5A, 5B, and 5C). As expected, the T cell area was negative for
CXCL13.
In addition to the conduit-associated reticular pattern,
dense CXCL13 staining colocalized with FSCs (gp38+) and
FDCs proximal and distal, respectively, to the SCS (Figures
5B and 5C). Moreover, higher-magnification images suggest
that the CXCL13 is wrapped by both FDCs and conduit struc-
tures (Figure 5C). Thus, the staining pattern suggests that
CXCL13 secreted by FSCs enters the conduit and could pro-
vide an attractant to guide B cells to a likely site of Ag
exposure. However, an alternative interpretation is that
FSC-secreted chemokine binds to the outer surface of the
FO conduit, as proposed for conduits in the T cell area. Im-
munostaining of sections from LNs containing labeled TEL
identify a similar pattern of staining for fibronectin, CXCL13,
and TEL Ag (Figure 5D). Thus, conduits include CXCL13, pos-
sibly to provide an attractant to B cells to survey the conduits
for the presence of Ag, as proposed for DCs in the T cell area
(Bajenoff et al., 2006).
It has been described that chemokines produced at the site of
inflammation, such as CCL2, can drain into LNs putatively viaFigure 2. Small Ags Are Rapidly Delivered to LN Follicles through FO Conduits
A633-TEL (red, containing 50 ng TEL) and TEL-PE (green, containing 5 mg TEL) were injected into the footpads of mice, and their entry into the draining LN was
monitored by MP-IVM (see also Movie S1).
(A) Intravital micrographs depicting the distribution of the small (A633-TEL, red) and large (TEL-PE, green) Ag in a B follicle early (55 s, left panel) or late (16 min,
40 s, right panel) after footpad injection (WT B = white; MD4 B = blue). The scale bar represents 30 mm.
(B) Micrographs from selected time points depicting either A633-TEL or TEL-PE. Time is shown in minutes and seconds.
(C) Regions of interest (ROIs) were defined for measuring the mean fluorescence intensity (MFI; individually normalized, averaged MFIs ± SEM versus time after
TEL injection) of A633-TEL and TEL-PE in the SCS, conduits (Cd. 1–3), and the interstitial space (Int. 1–3). Dotted lines indicate half-maximal values for TEL and
TEL-PE in conduits and interstitium.
(D) ROIs with increasing distance from the SCS were defined, and the normalized MFIs of A633-TEL (top panel) and TEL-PE (bottom panel) were plotted against
time after injection. This experiment was repeated twice with similar results.Immunity 30, 264–276, February 20, 2009 ª2009 Elsevier Inc. 269
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Small-Antigen Transport to B Cell FolliclesFigure 3. Characterization of the FO Conduits Network by Immunohistology and EM
(A) Imaging of thick cryosections (40 mm) stained for collagen I (green) and ER-TR7 (red) (top panels) or fibronectin (green) and perlecan (red) (middle panels) in B
cell follicles. The scale bars represent 100 mm. Hatched lines indicate the T-B cell border. The bottom panels show imaging of thick cryosections after s.c.
injection of Ag (TEL, green; collagen I, red; and CD35, blue). The hatched box identifies the area magnified in lower panels. The scale bars represent 100 mm
and 20 mm, respectively.
(B) Immunofluoresence on thin cryosections (10 mm) of LN after s.c. injection of Ag (TEL, green). The columns are arranged as follows: left column, collagen I (red
[the scale bar represents 20 mm]); second and third columns, ER-TR7 (red); fourth column, fibronectin (red); and fifth column, gp38 (red [scale bars represent
5 mm]).
(C) Ag transported via conduits is acquired by T cell-area dendritic cells (CD11c, left panel, red), FSCs (gp38, middle panel, red), and B cells (B220, right panel,
red). Scale bars represent 5 mm.
(D) Ultrastructural characterization of FO conduits. (i) Transmission EM of the SCS and the B cell follicle. The white arrowheads indicate part of a conduit in the
B cell follicle. The scale bar represents 1 mm. (ii) Electronmicrograph of a conduit (c) in the SCS area. FSC, SLC, andM represent follicular stromal cell, sinus-lining270 Immunity 30, 264–276, February 20, 2009 ª2009 Elsevier Inc.
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Small-Antigen Transport to B Cell FolliclesT cell area conduits in order to influence cellular recruitment via
HEVs (Palframan et al., 2001). To further examine a possible role
for conduits in the delivery of lymph-borne chemoattractants to
the follicles or in the distribution of locally produced chemokines
within the B cell area, we injected mice in the footpad s.c. with
a small volume of recombinant CCL21 (SLC). LNs were
immediately fixed in situ and harvested for analysis. CCL21 is
normally found in the T cell area, and, as expected, only
a background amount was observed within the B cell follicles
in uninjected mice (Figure S7, left panels). By contrast, the follic-
ular zone stained positive for CCL21within pLNs of mice injected
with the chemokine (Figure S7, right panels). Examination of sec-
tions at higher magnification revealed CCL21 colocalization with
FO conduits (Figure S7). Thus, the results are consistent with
a model in which lymph-borne chemoattractants also enter the
follicles (and paracortical region) via conduits.
DISCUSSION
It is generally accepted that protein Ags retained on FDCs
provide an important depot for encounter by FO B cells (Kosco
and Gray, 1992; Kelsoe, 2000; Fu et al., 1997; Cyster et al.,
2000; Rajewsky, 1996). HowAg is delivered to FDCs is less clear.
Using a combination of MP-IVM, EM, confocal, and flow-cyto-
metric analyses, we observe a unique pathway whereby small
soluble Ag drains passively into the B cell zone through a FO
conduit system that connects the SCS with FDC areas. More-
over, the FO conduit network, which is less dense but structurally
similar to that of the T cell zone, contains CXCL13. Thus, the
conduit system provides a source of Ag as well as a possible
pathway or network for guiding B cells to Ag within the follicles
in a similar manner as identified in the paracortex for T cells.
Qi et al. found that DCs loadedwith HEL ex vivo and adoptively
transferred into mice present Ag to HEL-specific B cells within
the paracortical region (Qi et al., 2006). They proposed that
conduit-associated DCs may take up draining Ag and present
it to B cells entering the T zone via HEVs. Using a similar model
Ag (HEL), Pape et al. tested the importance of DCs in Ag trans-
port in a mouse model in which CD11c+ cells were deleted prior
to injection of Ag (Pape et al., 2007). They found that DCs were
not essential, given that the HEL drained rapidly into the follicles
of the depleted mice and was detected on specific B cells within
3.5 min. They proposed a model in which small protein Ags
within the afferent lymph drain directly into the B cell follicles
via gaps in the SCS floor and in which cellular transport was
not required. Our findings are consistent with their report, given
that small Ag drained rapidly into follicles in an apparently cell-
independent manner. However, an important difference is that
TEL entered the follicles via discrete conduits rather than in
a diffuse pattern, representing a second mechanism in which
small Ags gain access to the B cell follicles. This discrepancy
could result from the different techniques employed to visualize
the Ag. In the Pape study, the draining LNswere flash frozen, and
cryosections were imaged ex vivo without hydration. In our
hands, Ag was only observed inside conduits when LNs werefixed in situ by perfusion via the lymph. It is possible that the flash
freezing of the LNs obscured a discrete pattern within FO con-
duits. Moreover, the conduits, which are readily observed by
MP-IVM, are not easily identified by confocal microscopy with-
out staining with specific antibodies.
Immunostaining with antibodies specific for type I collagen
identified colocalization of the labeled TEL. Furthermore, stain-
ing with Abs specific for basement membrane (fibronectin) or
stromal cell surface markers (ER-TR7 and gp38) indicates that
the Ag lies within, not outside, the conduit. Interestingly, the
conduits appear to merge or overlap with the FDC network, sug-
gesting that small Ags are ‘‘delivered’’ directly and can be taken
up if they are tagged with complement ligand C3 (Fang et al.,
1998; Fischer et al., 1998). Whether the primary role of conduits
is channeling of chemokines and inflammatory mediators or
delivery of B cell Ags is not clear. However, our results illustrate
that conduits provide an efficient mechanism for delivery of small
Ags from the SCS into the follicle, where they are efficiently
exposed to B cells.
The finding that TEL is taken up by FDCs more rapidly than
larger Ags, such as PE and KLH, which are excluded from
conduits, supports our observations that lymph-borne small
Ags rapidly fill conduits and drain into the underlying follicles.
In contrast, large Ags, such as PE, are bound by FO B cells
and delivered to FDCs in a complement-dependent manner, as
reported (Phan et al., 2007). However, the uptake of TEL by naive
B cells was less efficient, and the peak of uptake occurred earlier
than with PE. This suggests that some TEL does diffuse into the
follicles and is taken up by B cells as an IC or, alternatively, that
TEL Ag enters into the interstitial space after being distributed in
the follicle via conduits, as suggested by our MP-IVM results.
The observation of TEL entry into follicles via conduits is not
explained by an injection of an excessive amount of Ag. In the
current study, mice were injected with a mixture of TEL and
TEL-PE with less than 1 mg of TEL. This represents considerably
less Ag than used by Pape et al. (Pape et al., 2007). Importantly,
only the smaller TEL Ag was detected within the FO conduits.
Characterization of the FO conduits by ultrastructural analysis
and immunostaining suggests that their structure is similar to
that identified for those in the T zone. As reported by Gretz
et al. (Gretz et al., 2000), the FO conduits include a core of tightly
packed collagen fibrils with spaces of less than 10 nm, which
would explain the size exclusion of particles greater than
5.5 nmor approximately 70 kDa. As reported for T zone conduits,
conduits in the follicles stained positive for fibronectin and perle-
can, suggesting that the collagen core was enveloped by a base-
ment membrane (Sixt et al., 2005). Likewise, the FO conduits
stained positive for ER-TR7 and gp38, which are markers for
LN stromal cells.
In the current study, FO conduits were found to open into the
SCS, which would provide access to small lymph-borne Ags.
Although the conduits are ‘‘wrapped’’ by stromal cells, gaps
exposing the conduits to B cells were identified. Indeed, MD4
B cells closest to conduits were observed to bind TEL Ag more
rapidly than those that were more distal.cell, andmacrophage, respectively. The scale bar represents 2 mm. (iii) Electronmicrograph and (iv) schematic drawing of a transverse section of a FSC located in
the follicular area of the LN. The high metabolic activity of these cells is indicated by the presence of a prominent rough endoplasmic reticulum (RER) and
mitochondria (m); N represents nucleus. The scale bar represents 500 nm.Immunity 30, 264–276, February 20, 2009 ª2009 Elsevier Inc. 271
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Small-Antigen Transport to B Cell FolliclesOne difference between conduits in the follicles and those in
the T zone is that the former are less dense. One possible expla-
nation for this difference is the presence of the FDC network,
which is unique to the follicular region. Thus, the combination
of FDC processes and FO conduits would provide a rich network
for B cells to interact with Ag.
Rapid transport of small Ag into the follicles via conduits can
accelerate its encounter by cognate B cells. Comparison of up-
take and activation of MD4 B cells by TEL and TEL-PE revealed
more rapid activation by the smaller Ag, on the basis of CD86
expression and earlier migration of activated B cells to the T-B
cell border. Moreover, tracking of Ag-bound cognate B cells
within the first 15 min after injection of small Ag revealed
a dramatic slowing in their migration pattern relative to non-
Ag-binding control B cells. In the example of an infectious path-
ogen, this reduction in response time to microbially derived Ags
could provide a substantial benefit to the host (Ochsenbein et al.,
1999). Thus, Ag is delivered to the B cell follicles via conduits
within minutes after injection and, in the presence of Ig and
complement, is taken up on FDCs. These rapid kinetics could
be critical in the case of a highly infectious pathogen. Given
that intact pathogens exceed the size limit of the conduits, the
majority of the microbial Ag could be transported via B cells.
However, small secreted bacterial products and/or viral ‘‘build-
ing blocks’’ could drain into the B cell zone via the conduits.
Moreover, partial degradation of pathogens at the initial site of
infection would release smaller products that gain access to
the follicles via the FO conduits.
Recently, Bajenoff et al. reported that lymphocytes migrate
through the T zone along FRC-ensheathed conduits, presum-
ably in response to chemokines bound to the cell surface (Bajen-
off et al., 2006). Likewise, B cells were found to associate with
FDC processes, and it was proposed that they are guided by
CXCL13. The observation of such a close contact supports
a model in which Ag (and complement ligand) is exchanged
between the two cell types. In the current study, FO conduits,
FSCs, and FDCs colocalized with CXCL13. Staining of cryosec-
tions with specific antibody suggests that both FSCs and FDCs
are a source of CXCL13, as reported by Cyster et al. (Allen and
Cyster, 2008). Thus, one interpretation of our results is thatFSCs proximal to the SCS release CXCL13, and from there it
permeates the conduit network. Analogous to what has been
described in the T cell area (Bajenoff et al., 2006), this would pro-
vide a mechanism by which B cells are guided in their migration
through B cell follicles by the same structures that deliver Ag
draining from peripheral tissues, maximizing their exposure to
Ag.Whether CXCL13 enters the conduits or is bound to the outer
surface of the FSCs could not be determined definitively from our
analysis. However, the finding that CCL21 injected s.c. in the
footpad colocalizes with the FO conduits suggests that chemo-
kines like small protein Ags enter follicles via this route.
In summary, we identified a unique network of conduits in
peripheral LNs that mediate rapid transport of small soluble-
protein Ags from the SCS into the B cell follicular region. The
presence of conduits within the follicles provides an efficient
mechanism for exposing Ag to B cells and for rapid deposition
on FDCs.
EXPERIMENTAL PROCEDURES
Mice
All mice (CD45.1, CD45.2, MD4 [Goodnow et al., 1988], and Cr2/ [Molina
et al., 1996]) were maintained on a C57BL/6 (B6) background and housed
at Harvard Medical School and Immune Disease Institute animal facilities
under specific pathogen-free conditions. Studies were approved by the
institutional animal care and use committees. Mice received food and water
ad libitum.
Immunogens and Immunization Protocols
TEL and DEL were purified from fresh turkey eggs (Nicholas Turkey Breeding
Farms, Sonoma, CA, USA) as described (Prager and Wilson, 1971). B-PE and
KLH were from Sigma Aldrich (St. Louis, MO, USA). Ags were conjugated with
Alexa Fluor 488 (A488), 568 (A568), or 633 (A633) carboxylic acid succinimidyl
esters (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s
instructions. B-PE was covalently coupled to TEL with EDAC (Invitrogen,
Carlsbad, CA) and Sulfo-NHS (Pierce Biotechnology, Rockford, IL, USA) and
purified by gel filtration chromatography. For in vivo IC formation, mice were
passively immunized i.p. with 2 mg rabbit anti-lysozyme (Biodesign, Saco,
ME, USA), rabbit anti-KLH (GeneTex, San Antonio, TX, USA), or rabbit anti-
B-PE (Rockland, Gilbertsville, PA, USA) and 24 hr later injected s.c. in the
hind flanks with a mixture of 10 mg A488-TEL and 10 mg B-PE. The draining
inguinal LNs were isolated at various times for flow-cytometry and confocal-
microscopy analyses.Figure 4. Delivery of Ag to B cell by FO Conduits Leads to B cell Activation
(A) A subregion of the same data set as shown in Figure 2 is shown at different time points. The short arrow indicates initial appearance of A633-TEL on a B cell in
this region. The long arrow indicates a conduit in which A633-TEL is first detected. The arrowhead indicates MD4 B cells that remain free of or accumulate only
minute amounts of A633-TEL. Time is shown in minutes and seconds. See also Movie S2.
(B) A limiting amount of A633-TEL (red, containing 10 ng TEL) was injected into the footpad of a differentmouse seededwithMD4 (blue) andWTB cells (green); the
draining LN was monitored by MP-IVM (see also Movie S3), and the micrograph was taken 170 s after TEL injection. Magnified regions of interest highlight the
close spatial relation of selected TEL+ MD4 B cells to TEL-containing conduits. The scale bar represents 30 mm.
(C) Quantification of TEL uptake by MD4 B cells (as measured by MFI) as a function of proximity to the nearest TEL+ conduit. Similar results were obtained in
a separate experiment.
(D) Electron micrographs of a B cell follicle (i and iii) and schematic drawing (ii) showing B cell processes in close contact with a conduit. The SLCs that separate
the SCS from the B cell follicle are indicated in orange. Scale bars represent 1 mm (i) and 500 nm (iii).
(E) The acquisition of A633-TEL versus TEL-PE byMD4B cells was assessed over a 4 hr period by FACS. Representative plots, gated on IgMa+ cells that acquired
Ag in vivo (labeled MD4 cells were added ex vivo to capture free Ag), from four LNs analyzed in two experiments are shown. Average values ± SEM of
Ag acquisition by MD4 B cells are shown in the graph (*p = 0.004, **p = 0.03).
(F) Upregulation of CD86 on MD4 B cells by TEL or TEL-PE. The graph shows percentages of MD4 B cells expressing CD86 at 1, 2, 3, 4, 6, and 8 hr after
Ag injection. Average values ± SEM from at least two LNs from three experiments are shown.
(G) Location of MD4 B cells in the inguinal LNs of mice that received no Ag, TEL, or TEL-PE 8 hr earlier. Results from two experiments were analyzed for the
numbers of MD4 B cells localized to two zones, one for cells within the follicles and one for cells that were in a ROI within 22 mm of the paracortical-follicular
border or extrafollicular, and these data were used for compiling the graph.Immunity 30, 264–276, February 20, 2009 ª2009 Elsevier Inc. 273
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Small-Antigen Transport to B Cell FolliclesFigure 5. CXCL13 Is Associated with FO Conduits
(A) Immunofluorescencemicrographs of B cell follicles stained with antibodies against fibronectin (green), ER-TR7 (red), and CD35 (blue). T-B cell boundaries are
indicated by hatched lines. Scale bars represent 100 mm (top) and 20 mm (bottom).
(B) LN cryosections stained for CXCL13 (red), fibronectin (green, left and middle columns [scale bars represent 100 and 20 mm]), and gp38 (green, right column
[the scale bar represents 20 mm]).
(C) CXCL13 (red) is localized in lymph node follicles and associates with collagen I (blue) and CD35 (green). Hatched boxes indicate magnified areas. Scale bars
represent 100 mm for overview and 20 mm and 5 mm for large and small magnified areas, respectively.
(D) Antigen (TEL, green) and CXCL13 (red) colocalize in a conduit-like pattern with fibronectin (blue). Hatched boxes indicate magnified areas. Scale bars
represent 100 mm for overview and 20 mm for magnified areas.Antibodies
The following antibodies were used for flow cytometry and immunohistochem-
istry: aCD33-Biotin, aCD19-PE, aCD21/35-FITC (7G6), aCD35-Cy5 (8C12),
aCD35-Biotin, aCD45.1-PE and FITC, aCD45.2-FITC, aB220-PerCP, aIgMa-
Biotin and Streptavidin-APC (BD Biosciences, San Jose, CA, USA); aB220-
Pacific Blue, aCD86-Biotin, Streptavidin-PE/Cy7 (eBiosciences, San Diego,
CA, USA); aB220-Cy5, goat anti-rabbit IgG-A488 (Invitrogen); acollagen I
(Chemicon,Temecula,CA,USA);aperlecanandafibronectin (Neomarkers, Fre-274 Immunity 30, 264–276, February 20, 2009 ª2009 Elsevier Inc.mont, CA, USA); and aCXCL13-Biotin (R&D Systems, Minneapolis, MN, USA).
Antibodies specific for ER-TR7, CD35 (8C12), gp38 (8.1.1), CD11c (N418), and
B220 (6B2) were produced in house and conjugated to A488 or A647 or de-
tected with the appropriate Alexa-labeled secondary staining reagents.
Single-Cell Suspensions and FACS Analysis
Single-cell suspensions from LNs were blocked with anti-FcR (2.4G2) and
stained with antibodies listed above in PBS containing 1% fetal bovine serum.
Immunity
Small-Antigen Transport to B Cell FolliclesEither FACSCalibur or a FACSAria (BD Biosciences, San Jose, CA, USA) flow
cytometer and FlowJo software (Tree Star, Ashland, OR, USA) were used for
analysis.
Histology
Cryosections of OCT (Tissue tek, Torrence, CA, USA)-embedded LN were
prepared as described (Verschoor et al., 2001) and incubated with anti-FcR
(2.4G2) before treatment with antibodies listed above in Earle’s balanced
salt solution containing 1.5% bovine serum albumin and 0.1% saponin for
conduit components and CXCL13. Images were acquired with a DM6000
fluorescence microscope and an SP2 confocal microscope (Leica Microsys-
tems, Wetzlar, Germany) and processed with Leica image viewer, Adobe
Photoshop, and ImageJ software. In some cases, pseudocolor channels
were swapped for visual representation.
B Cell Isolations, Labeling, and Adoptive Transfers
Naive (CD43) B cells from WT and MD4 spleens were magnetically enriched
(Miltenyi Biotec, Auburn, CA, USA) to more than 90% purity. For MP-IVM
studies, splenocytes were labeled with CellTracker dyes (Invitrogen), CMFDA
at 2.5 mMor CMAC at 20 mM, for 15min, followed by extensive washing prior to
B cell isolation. Recipient mice received a 1:1 mixture of labeled WT and MD4
B cells (33 107 cells/mouse) or MD4 only (1.5 3 107) for Ag uptake and B cell
activation assays i.v. at least 20 hr prior to Ag injection.
Multiphoton Intravital Microscopy
MP-IVM was performed as described (Mempel et al., 2004). For detailed
methods, see Supplemental Experimental Procedures.
Electron-Microscopic Analysis
pLNs were dissected and fixed in 2% formaldehyde or 2.5% glutaraldehyde in
0.1 M sodium cacodylate buffer (pH 7.4) overnight at 4C. LNs were washed in
cacodylate buffer and osmicated with 1% osmium tetroxide and 1.5% potas-
sium ferrocyanide (in water) for 1 hr at 18C–22C in the dark. LNs were
washed in water and then in 0.05 M maleate buffer (pH 5.15), counterstained
for 2 hr in 1% uranyl acetate in maleate buffer, and washed in water. The sam-
ples were dehydrated by incubation for 15 min in ethanol in water (60%, 90%,
and 100%), incubated in propylene oxide for 1 hr, and transferred into Epon
mixed 1:1 with propylene oxide at room temperature overnight. The samples
were moved to an embedding mold filled with freshly mixed Epon and heated
for 24–48 hr at 0C for polymerization. Samples were analyzed on a Tecnai G2
Spirit BioTWIN electron microscope (FEI Company, Hillboro, Oregon, USA) at
the Harvard Medical School EM Facility.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, seven
figures, and four movies and can be found with this article online at http://
www.immunity.com/supplemental/S1074-7613(09)00063-6.
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